Business, energy, technology, markets and global industry news from Business News Today

Skip to content

Home
Pharma & Biotech
Medical Devices & Diagnostics
Features & Analysis

Home
Pharma & Biotech
Medical Devices & Diagnostics
Features & Analysis

Xifaxan

PharmaDeviceNews Xifaxan

OneLegacy’s partnership with OrganOx aims to expand access to normothermic liver perfusion technology and help Southern California transplant centres evaluate and preserve more donor livers for transplantation. Representative image.

Pharma & Biotech

Bausch Health presents 1,630-patient liver disease study at AASLD 2026

by Pallavi Madhiraju
November 6, 2026
0 Comments

Salix reports 62% one-year survival and high rehospitalisation in severe alcohol-associated hepatitis, highlighting gaps in long-term care.

Read More

Latest news and features

Gilead Sciences’ Livdelzi achieves 75% ALP normalisation response in Phase 3 IDEAL trial
Vir Biotechnology’s ECLIPSE-1 data arrive Sunday. Can monthly therapy challenge Hepcludex?
Ellipsis Health buys Kouper Health, but can AI finally close the gaps between patient visits?
FX Shoulder Solutions brings stemless reverse shoulder replacement to the US, but is the evidence ready?
Rybrevant Faspro shrank tumours in 42% of patients, but can Johnson & Johnson prove survival benefit?
Ivonescimab clears half of lung tumours before surgery, but can Akeso prove lasting benefit?
Cleerly’s AI can quantify coronary plaque. Can 530-patient PARAMOUNT prove it changes care?
BayCare’s $33m proton centre fits inside a conventional radiation vault. Could this change cancer care economics?
CareValidate promises same-day GLP-1 delivery, but can it solve telehealth’s last-mile problem?
Lynk Pharmaceuticals advances zemprocitinib towards China approval after positive Phase 3 rheumatoid arthritis results
Kos Biotechnology Partners backs Fathom Therapeutics’ US$55m AI drug discovery financing
Bausch Health presents 1,630-patient liver disease study at AASLD 2026

POPULAR NEWS

plated Skin Science’s new BODY Serum brings platelet-derived exosome skincare beyond the face, targeting signs of aging, texture and hydration across the body. Representative image.

Pharma & Biotech

Rion Aesthetics expands plated Skin Science exosome platform with $338 BODY Serum

August 19, 2026

Pharma & Biotech

Omabit raises $2m to connect fragmented clinical evidence, but can AI improve drug development decisions?

October 27, 2026

Medical Devices & Diagnostics

Presage Technologies SmartSpectra cleared for contactless vital signs monitoring

July 8, 2026

Latest business and industry news

TC Energy approves C$3bn pipeline projects as AI power demand drives gas expansion
Cloudflare revenue jumps 39% to $782.5m, but GAAP losses raise a bigger question
US expands Cuba sanctions to technology, shipping and manufacturing sectors
Freeport-McMoRan (FCX) approves $4.5bn copper expansion as shares fall 7.5%
Adani Ports (ADANIPORTS) targets Evos in €2.56bn deal, but can debt-funded expansion deliver returns?

TAGS

AstraZeneca clinical trials Eli Lilly and Company European Medicines Agency FDA immunotherapy Inc. Johnson & Johnson medical devices non-small cell lung cancer oncology precision oncology U.S. Food and Drug Administration United States Food and Drug Administration US Food and Drug Administration

About PharmaDeviceNews
Disclaimer
Editorial Policy
Privacy Policy
Contact Us

© 2026 PharmaDeviceNews.com. All rights reserved.